TCL Archive Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.” October 29, 2004
TCL Archive FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment. September 28, 2001
TCL Archive Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease February 22, 2013
TCL Archive Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy” March 8, 2002